Home › Free Stock Grades › LUCD
Lucid Diagnostics Inc. (LUCD) Stock Grade
LUCD · Healthcare
C
Market Cap
$153.7M
P/E Ratio
—
Revenue Growth (YoY)
+8.3%
Net Margin
-1232.7%
Return on Equity
—
Dividend Yield
None
About Lucid Diagnostics Inc.'s fundamentals
Lucid Diagnostics is a medical device company with a market capitalization of $153.7 million that generated 8.3% year-over-year revenue growth in its latest period. However, the company is currently unprofitable, reporting a net loss with a net margin of -1232.7%, indicating it is spending significantly more than it generates in revenue. The company does not pay a dividend and lacks positive returns on equity, reflecting its early-stage or development-focused operational status.